Check out my 20 minute video about the ongoing AMRN ANDA appeal. It includes valuable information include key dates in the litigation as well as the #1 misconception of biotech investors regarding this litigation. Plus, there's info about our paid subscription service where you can get my ongoing insights as this litigation unfolds, including instant access to $10,000s of my team's legal research, including an event that you likely don't know could be the most impactful event of the appeal other than the final ruling, and at a price retail investors can afford.
(free sign-up required. We only use your email for occasional emails from Amp.)